Works matching IS 00070920 AND DT 2012 AND VI 107 AND IP 2


Results: 33
    1

    A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network.

    Published in:
    2012
    By:
    • Mross K;
    • Dittrich C;
    • Aulitzky WE;
    • Strumberg D;
    • Schutte J;
    • Schmid RM;
    • Hollerbach S;
    • Merger M;
    • Munzert G;
    • Fleischer F;
    • Scheulen ME;
    • Mross, K;
    • Dittrich, C;
    • Aulitzky, W E;
    • Strumberg, D;
    • Schutte, J;
    • Schmid, R M;
    • Hollerbach, S;
    • Merger, M;
    • Munzert, G
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network

    Published in:
    British Journal of Cancer, 2012, v. 107, n. 2, p. 280, doi. 10.1038/bjc.2012.257
    By:
    • Mross, K;
    • Dittrich, C;
    • Aulitzky, W E;
    • Strumberg, D;
    • Schutte, J;
    • Schmid, R M;
    • Hollerbach, S;
    • Merger, M;
    • Munzert, G;
    • Fleischer, F;
    • Scheulen, M E
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33